What is Quantitative Acetyl-Proteomics? A Comprehensive Analysis of Technical Principles and Application Prospects
Post-translational modification (PTM) of proteins is one of the core mechanisms regulating protein functions. Lysine acetylation is gradually becoming one of the most focused PTM types after phosphorylation. Acetylation modifications are involved in various biological processes such as transcriptional regulation, metabolic regulation, cell cycle, and signal transduction. Its abnormal changes are closely related to various diseases (e.g., cancer, metabolic syndrome, neurodegenerative diseases). With the continuous advancement of mass spectrometry technology, a focus on acetylation modifications has emerged.High-throughput proteomics technology - Quantitative Acetyl-Proteomics.，Quantitative Acetyl-Proteomics.It is gradually becoming an important tool in life sciences research.It not only precisely captures the panoramic map of protein acetylation but also quantitatively compares the dynamic changes of modification states under different biological conditions, serving as a crucial method for exploring cellular regulatory mechanisms, disease mechanisms, and drug target discovery.
What is Quantitative Acetyl-Proteomics?
Quantitative Acetyl-Proteomics.This is a high-throughput research technique focused on identifying, characterizing, and quantitatively analyzing protein acetylation modification sites, typically combining anti-acetyl-lysine antibody enrichment strategies with high-resolution mass spectrometry for data acquisition.
The main research goals include:
1. Comprehensive mapping of protein acetylation sites (acetylome profiling).
2. Comparing dynamic changes in acetylation modification levels among different treatment groups.
3. Revealing signal pathways and functional networks regulated by acetylation.
Compared to traditional proteomics, quantitative acetyl-proteomics sets higher requirements for sample processing, enrichment methods, quantitative methods, and data analysis.
Core technical principles of Quantitative Acetyl-Proteomics.
1. Sample preparation and protein digestion.
Research usually involves extracting total proteins from cells or tissues, followed by standard steps such as reduction and alkylation, before trypsin digestion to generate peptides.
2. Antibody enrichment of acetylated peptides.
Since acetylated peptides constitute a very small proportion of the total peptide pool (<1%), they require enrichment via 'specific anti-acetyl-lysine antibodies' to greatly enhance detection sensitivity and coverage of modification sites.
3. Selection of quantitative strategies.
(1) Labeling-based methods:Such as TMT (Tandem Mass Tag) and iTRAQ, suitable for parallel analysis of multiple sample groups.
(2) Label-free methods:Based on peptide peak area comparison, flexibly adapting to different sample numbers.
（3）SILAC（Stable Isotope Labeling by Amino acids in Cell culture）：Applicable for tracking acetylation dynamic changes in cell experiments.
4. LC-MS/MS analysis and data interpretation.
(1) Enriched acetylated peptides are detected using 'high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS).' Platforms such as Orbitrap Exploris and Q Exactive HF enable high-throughput, high-sensitivity identification of modification sites.
(2) Data analysis relies on software like MaxQuant, Proteome Discoverer, and Spectronaut, combined with the Uniprot database to annotate acetylation sites, followed by GO/KEGG pathway analysis, protein interaction network construction, etc.
Research value of Quantitative Acetyl-Proteomics.
1. Decoding epigenetic regulatory mechanisms.
Histone acetylation directly participates in chromatin state regulation, affecting gene transcription activity. Quantitative acetyl-proteomics can reveal regulatory networks of transcription factors, co-factors, and chromatin remodeling factors.
2. Exploring functional regulation of metabolic enzymes.
Many metabolism-related enzymes such as GAPDH, PDH, ACLY, etc., have lysine acetylation modifications that regulate their activity, stability, and subcellular localization. Quantitative studies help establish regulation models of acetylation in metabolic pathways.
3. Discovering potential drug targets and biomarkers.
In certain disease states, specific protein acetylation sites undergo significant changes, serving as potential diagnostic markers or therapeutic targets, especially prominent in cancer, inflammation, and neurological disease research.
Application scenarios and case studies of Quantitative Acetyl-Proteomics.
1. Cancer research.
For instance, in liver cancer research, quantitative acetyl-proteomics reveals that HDAC inhibitor treatment enhances acetylation of multiple oncogenic pathway proteins, closely related to cell cycle inhibition.
2. Metabolic diseases.
In insulin resistance research, changes in acetylation states of certain key glucose metabolism enzymes are found to be closely related to metabolic disorders, suggesting acetylation regulation as a new therapeutic target.
3. Exploring drug mechanisms of action.
Small molecule drugs targeting histone deacetylases (HDACs) or acetyltransferases (HATs) can be tracked for efficacy mechanisms through acetyl-proteomics.
Challenges and future trends in Quantitative Acetyl-Proteomics.
1. Current technical bottlenecks in Quantitative Acetyl-Proteomics.
(1) Efficiency and specificity of acetylation site enrichment need improvement.
(2) Quantitative reproducibility of low-abundance modified peptides shows variability.
(3) Insufficient data interpretation capabilities limit the depth of bioinformatics mining.
2. Future development directions in Quantitative Acetyl-Proteomics.
(1) Multi-omics integrative analysis (e.g., acetylation + phosphorylation).
(2) Functional validation of site-specific acetylation (mutation, CRISPR editing).
(3) AI-driven modification network prediction and disease model construction.
Quantitative acetylation proteomics is not only a frontier tool for exploring epigenetic regulatory mechanisms but also a tool for precision medicine and target development. In the practice of quantitative acetylation proteomics, sample quality control, antibody screening, mass spectrometry platform selection, and data interpretation are key to determining the success of a project. Relying on over a decade of proteomics technology accumulation, Biotech Pack has established a comprehensive acetylation modification research platform. We have successfully serviced hundreds of acetylation modification studies, covering oncology, metabolism, immunity, autophagy, and other fields. If you are conducting related research or wish to quickly build a high-quality acetylation proteomics data system, Biotech Pack is your trusted scientific research partner. For an acetylation proteomics research service manual or experimental design consultation, please visit our website or contact our technical support team.
Biotech Pack - A high-quality service provider for bioproduct characterization and multi-omics mass spectrometry analysis
Related services:
How to order?
